VEGFA and preeclampsia: Our hypothesis that preeclampsia history would be associated with increased risk of restenosis is derived from animal models in which excessive exposure to the Sflt‐1 receptor, a likely downstream mediator of preeclamptic symptoms as an antagonist of vascular endothelial growth factor, caused long‐term disruption of healing following vascular injury.8